Chr Rønn Hansen (@christian_roenn) 's Twitter Profile
Chr Rønn Hansen

@christian_roenn

Medical physicist at Odense University Hospital and Danish Particle Center within H&N RT research. A keen member of #DAHANCA

ID: 925617267219496960

linkhttps://orcid.org/0000-0001-5716-6069 calendar_today01-11-2017 06:55:28

832 Tweet

481 Takipçi

477 Takip Edilen

DCCC_Radiotherapy (@dccc_rt) 's Twitter Profile Photo

📆We hope you have already marked your calendar on May 28! 📣 Well after ESTRO, we are happy to host this upcoming webinar on updates from the national #interdisciplinary network for #QA in #MR images in #radiotherapy! More information: straaleterapi.dk/en/news-events…

📆We hope you have already marked your calendar on May 28! 📣 Well after ESTRO, we are happy to host this upcoming webinar on updates from the national #interdisciplinary network for #QA in #MR images in #radiotherapy! 

More information: straaleterapi.dk/en/news-events…
Henning Willers, MD, FASTRO (@henningwillers) 's Twitter Profile Photo

1/ Next up NARLA2 #LUNGCANCER trial at #ESTRO24🔥🔥🔥 PET guided dose escalation phase III (because 60-66 Gy is not high enough for many tunors‼️)

1/ Next up NARLA2 #LUNGCANCER trial at #ESTRO24🔥🔥🔥

PET guided dose escalation phase III (because 60-66 Gy is not high enough for many tunors‼️)
Henning Willers, MD, FASTRO (@henningwillers) 's Twitter Profile Photo

2/ NARLA2 at #ESTRO24 Early local control improved with dose escalarion ‼️ (As some ofbuse would expect😎) No increase in toxicity Survival data yet to come 🔥🔥🔥

2/ NARLA2 at #ESTRO24 

Early local control improved with dose escalarion ‼️ 
(As some ofbuse would expect😎)

No increase in toxicity

Survival data yet to come 🔥🔥🔥
Søren M Bentzen (@sorenbentzen) 's Twitter Profile Photo

NARLAL2 phase III  trial (N=350) of dose escalation to the FDG avid area vs. standard RT for LA-NSCLC show improved loco-regional control with unchanged toxicity. Congrats to Tine Schytte and colleagues. OS not shown but allegedly “not disappointing” according to TS😊 #ESTRO2024

NARLAL2 phase III  trial (N=350) of dose escalation to the FDG avid area vs. standard RT for LA-NSCLC show improved loco-regional control with unchanged toxicity. Congrats to <a href="/TineSchytte/">Tine Schytte</a> and colleagues. OS not shown but allegedly “not disappointing” according to TS😊 #ESTRO2024
Chr Rønn Hansen (@christian_roenn) 's Twitter Profile Photo

The #DAHANCA group on the big stage at #ESTRO24. Ruta presented the influence of GTV-CTV margin on dysphagia risk at 6 and 12 m. Next step is a prospective trial with 0 vs 5 mm margin #DAHANCA41 🇩🇰💪

The #DAHANCA group on the big stage at #ESTRO24. Ruta presented the influence of GTV-CTV margin on dysphagia risk at 6 and 12 m. Next step is a prospective trial with 0 vs 5 mm margin #DAHANCA41 🇩🇰💪
Chr Rønn Hansen (@christian_roenn) 's Twitter Profile Photo

Another #realworlddata study from #DAHANCA with +3000 HN cancer patients presented by Pernille Lassen. Following the guidelines is a major predictor for OS and DFS 💪 🇩🇰

Another #realworlddata study from #DAHANCA with +3000 HN cancer patients presented by Pernille Lassen. Following the guidelines is a major predictor for OS and DFS 💪 🇩🇰
Phiro Tweets (@phirotweets) 's Twitter Profile Photo

Congratulations to Virginia Gambetta on her award for the work "Partial adaptation for online-adaptive proton therapy triggered by prompt gamma imaging" #MedPhys #ESTRO2024

Congratulations to Virginia Gambetta on her award for the work
"Partial adaptation for online-adaptive proton therapy triggered by prompt gamma imaging"
#MedPhys #ESTRO2024
Chr Rønn Hansen (@christian_roenn) 's Twitter Profile Photo

A great #ESTRO2024 is coming to an end. However, a great last session before de final debate 🤓 treatment planning studies can help improve clinical trials and sometimes even avoid running trials where we know the results from simulations 🤔🤓

Signe Bergliot Nielsen (@signebergliot) 's Twitter Profile Photo

Welcoming everyone with an interest in head and neck cancer of unknown primary to participate in my PhD defence in Aarhus, on the 31st of May.

Welcoming everyone with an interest in head and neck cancer of unknown primary to participate in my PhD defence in Aarhus, on the 31st of May.
European Congress of Medical Physics (@ecmp2026) 's Twitter Profile Photo

⚠️ Act fast! Early bird pricing for #ECMP2024 ends on 31 May. Don't miss your chance to connect with top minds in medical physics. Register now and save! 🔗 ecmp2024.org/registration-1 #ECMP2024 #EFOMP #ECMP #medicalphysics

⚠️ Act fast! Early bird pricing for #ECMP2024 ends on 31 May. Don't miss your chance to connect with top minds in medical physics. Register now and save! 🔗 ecmp2024.org/registration-1
#ECMP2024 #EFOMP #ECMP #medicalphysics
European Congress of Medical Physics (@ecmp2026) 's Twitter Profile Photo

🚨 Attention ECMP2024 Participants! 🚨 Beware of spam emails offering hotel bookings for ECMP2024! We've noticed an increase in fraudulent emails claiming to offer accommodation for our Congress. Please be cautious & only book through official channels provided by the ECMP2024

European Congress of Medical Physics (@ecmp2026) 's Twitter Profile Photo

Reduced Participation fee for #ECMP2024 for students in Bachelor's & Master's degree programs enrolled at a German, Austrian or Swiss university, we offer a subsidized participation fee. 👉🏻 Check all the details here: ecmp2024.org/partner/travel… #ECMP2024 #EFOMP #ECMP #medicalphysics

Reduced Participation fee for #ECMP2024 for students in Bachelor's &amp; Master's degree programs enrolled at a German, Austrian or Swiss university, we offer a subsidized participation fee.
👉🏻 Check all the details here: ecmp2024.org/partner/travel…
#ECMP2024 #EFOMP #ECMP #medicalphysics
Camilla Panduro (@camillapanduro_) 's Twitter Profile Photo

#AI is taking over OAR contouring. To ensure a safe transition from manual to AI contouring, we need agreed definitions. The #DAHANCA group revised OAR guidelines and quantified 3D contouring variation: shorturl.at/Iu3gj 3D OARs: shorturl.at/x024T Chr Rønn Hansen

DCCC (@dccccancer) 's Twitter Profile Photo

På #DKD2024 sætter vi kræftpakken for hoved-halskræft under spotlight. Indtil nu har vi ikke haft viden om risikoen for at overse kræft i den hurtige kræftpakkeudredning. Ida Grunske Schmidt fra OUH Odense Svendborg har gode nyheder med til os, når hun indtager scenen d. 29.08 #SamarbejdeOmKræft

Chr Rønn Hansen (@christian_roenn) 's Twitter Profile Photo

Happy see my clever PhD student doing so well. She gave a fantastic lecture on how to use #AI in clinical trials and what medical physicists can do to improve trials 💪

DCCC_Radiotherapy (@dccc_rt) 's Twitter Profile Photo

The DCCC RT Annual Meeting programme Nov 18-19 is ready! Incl. sessions on adaptive RT, new WP's, NARLAL2, an interactive Rethink-session, flash talks, emerging trials, closing debate on inclusion in trials. Full programme & registration👉danish.events/dccc-rt-annual…🗓️Deadline Oct 10.

The DCCC RT Annual Meeting programme Nov 18-19 is ready! Incl. sessions on adaptive RT, new WP's, NARLAL2, an interactive Rethink-session, flash talks, emerging trials, closing debate on inclusion in trials. Full programme &amp; registration👉danish.events/dccc-rt-annual…🗓️Deadline Oct 10.
Chr Rønn Hansen (@christian_roenn) 's Twitter Profile Photo

New guidelines highlight the role of medical physicists in clinical trials! From ensuring QA to contributing to trial design & statistical analysis, physicists bring essential expertise. DOI: 10.1016/j.ejmp.2024.104821 #MedPhys #ClinicalTrials #Radiotherapy #MedicalPhysics

New guidelines highlight the role of medical physicists in clinical trials! From ensuring QA to contributing to trial design &amp; statistical analysis, physicists bring essential expertise. 
DOI: 10.1016/j.ejmp.2024.104821 
#MedPhys #ClinicalTrials #Radiotherapy #MedicalPhysics